Long-term follow-up of an activated PI3K-δ syndrome 2 in patient presenting with an agammaglobulinemia phenotype

Ann Allergy Asthma Immunol. 2018 Dec;121(6):739-740.e1. doi: 10.1016/j.anai.2018.07.043. Epub 2018 Aug 4.

¹ Department of Clinical Immunology, Saint-Louis Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.
² Study Center for Primary Immunodeficiencies, Necker-Enfants Malades Hospital, Assistance Publique Hôpitaux de Paris, Necker Medical School, Paris, France; Paris Descartes University, Sorbonne Paris Cité, Paris, France.
³ Department of Clinical Immunology, Saint-Louis Hospital, Assistance Publique Hôpitaux de Paris, Paris, France; Study Center for Primary Immunodeficiencies, Necker-Enfants Malades Hospital, Assistance Publique Hôpitaux de Paris, Necker Medical School, Paris, France.
⁴ Study Center for Primary Immunodeficiencies, Necker-Enfants Malades Hospital, Assistance Publique Hôpitaux de Paris, Necker Medical School, Paris, France; INSERM UMR1163, Imagine Institute, Paris Descartes University, Paris, France.
⁵ Department of Clinical Immunology, Saint-Louis Hospital, Assistance Publique Hôpitaux de Paris, Paris, France; EA3518, Université Paris Diderot Paris 7, Paris, France. Electronic address: [email protected].

No abstract available

Publication types